<DOC>
	<DOCNO>NCT01101932</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , pharmacokinetics pharmacodynamics ( drug effect certain target sit activity body ) escalate dose oral PF-04308515 healthy volunteer 14 day well one oral dose tablet formulation administer 1 day .</brief_summary>
	<brief_title>Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male 18 55 year , inclusive Healthy females 18 44 year , inclusive Females require surgically sterile Evidence history clinically significant disease Postmenopausal woman History intolerance significant adverse effect glucocorticoid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics/Pharmacodynamics</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>